Cargando…
Mesenchymal stem cells (MSCs) as skeletal therapeutics–an update
Mesenchymal stem cells hold the promise to treat not only several congenital and acquired bone degenerative diseases but also to repair and regenerate morbid bone tissues. Utilizing MSCs, several lines of evidences advocate promising clinical outcomes in skeletal diseases and skeletal tissue repair/...
Autores principales: | Saeed, Hamid, Ahsan, Muhammad, Saleem, Zikria, Iqtedar, Mehwish, Islam, Muhammad, Danish, Zeeshan, Khan, Asif Manzoor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833928/ https://www.ncbi.nlm.nih.gov/pubmed/27084089 http://dx.doi.org/10.1186/s12929-016-0254-3 |
Ejemplares similares
-
Investigation of Olea ferruginea Roylebark extracts for potential in vitroantidiabetic and anticancer effects
por: LIAQAT, Samra, et al.
Publicado: (2021) -
Aberrant gene expression profiles, during in vitro osteoblast differentiation, of telomerase deficient mouse bone marrow stromal stem cells (mBMSCs)
por: Saeed, Hamid, et al.
Publicado: (2015) -
Docetaxel-Loaded Methoxy poly(ethylene glycol)-poly (L-lactic Acid) Nanoparticles for Breast Cancer: Synthesis, Characterization, Method Validation, and Cytotoxicity
por: Miraj, Shumaila, et al.
Publicado: (2023) -
A randomized control trial of primary care-based management of type 2 diabetes by a pharmacist in Pakistan
por: Javaid, Zaida, et al.
Publicado: (2019) -
Perceptions of and barriers to ethical promotion of pharmaceuticals in Pakistan: perspectives of medical representatives and doctors
por: Gul, Rehan, et al.
Publicado: (2021)